Research Insight
Research Insight
Autoimmune Response Can Induce Pancreatic Tumor Rejection
According to new scientific findings published in Cancer Research, a journal of the American Association for Cancer Research stating that, Immune responses are capable of...
Research Insight
Clinical Trial at CINJ examines shorter course of Radiation Treatment for Early-Stage Breast Cancer
Researchers at The Cancer Institute of New Jersey (CINJ) have launched a clinical trial that focuses on a shorter course of radiation treatment for those...
Research Insight
Technology Can Reverse The Effects of Some Strokes
According to the National Stroke Association, Stroke is the third leading cause of death in America and the number one cause of adult disability. According...
Research Insight
Calypso Medical Study shows potential for improving radiotherapy treatment accuracy of deadly pancre
Calypso Medical Technologies, Inc., announced the publication of data from a clinician sponsored investigational study conducted at the University of Pennsylvania, demonstrating the utility of...
Research Insight
Botox-maker Allergan Inc.announced the second-quarter profit early Friday
Botox-maker Allergan Inc. announced the second-quarter profit early Friday, the figures were substantially higher, attributable in part to the company's cost-cutting measures.
Botox-maker Allergan Inc. announced...
Research Insight
Researchers have noticed that two proteins may be key to screening for early-stage liver cancer
Researchers have identified an improved method of screening high-risk patients for one of the most common types of liver cancer, hepatocellular carcinoma. (HCC), particularly if...
Research Insight
New research finds Edwards Lifesciences’ Port Access System facilitates improved outcomes compared t
Edwards Lifesciences Corporation, the global leader in the science of heart valves, announced that new research demonstrates that using its minimally invasive PORT ACCESS System...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read